Tesamorelin 2mg
Size: 2mg | 99% Purity
nM.Wt: 5135.78
nFormula: C221H366N72O67S
nSolubility: H2O
nPurity: >99%
nStorage: -20°C / 3 years
nHalf life: ~26 minutes
nCAS No.: 218949-48-5
n
| Purity (HPLC) | >99% |
|---|---|
| Molecular weight | 5135.78 g/mol |
| Molecular formula | C221H366N72O67S |
| CAS number | 218949-48-5 |
| Synonyms | Tesamorelin, TH9507, Trans-3-hexenoic acid-GRF(1-44) |
| Solubility | H2O |
| Storage | '-20°C / 3 years |
| Half-life | ~26 minutes |
Research reference: View mechanism, literature and identifier graph →
Reconstitution calculator (pre-filled for 2 mg)
HPLC and MS verified by UKAS-accredited laboratories.
Free on orders over £50. Next-day upgrade available.
COA and batch number on every vial.
Tesamorelin 2mg — research reference material
n
Tesamorelin 2mg is supplied by ADIPHEX as a research reference material in a 2mg presentation. Compound class: GHRH(1-44) analogue with N-terminal fatty acid · 44-residue peptide, characterised in the literature as a growth-hormone-releasing-hormone analogue. It is supplied strictly for in-vitro laboratory research and is not for human or veterinary use.
n
Research context
n
GHRH analog; studied in visceral-fat, GH/IGF-1 research. Full mechanism detail, the identifier graph and selected peer-reviewed literature are set out on our Tesamorelin research reference. Related compounds in the same research area: CJC-1295 (No DAC), CJC-1295 (with DAC), Ipamorelin, GHRP-2. You can also compare it side by side on our comparison tool.
n
Presentation
n
This listing is the 2mg presentation at >99% stated purity, catalogue reference TSM2.
n
Identifiers
n
- n
- CAS number: 218949-48-5
- Molecular formula: C221H366N72O67S
- Molecular weight: 5135.78 g/mol
- Synonyms: Tesamorelin, TH9507, Trans-3-hexenoic acid-GRF(1-44)
- Class: GHRH(1-44) analogue with N-terminal fatty acid · 44-residue peptide
n
n
n
n
n
n
Format & quality
n
Supplied as 2mg at >99% purity. Identity and purity are characterised by reversed-phase HPLC and mass spectrometry, with a per-batch Certificate of Analysis available on request. This item is a lyophilised powder and requires reconstitution before use; bacteriostatic water is supplied separately, and our reconstitution guide covers volumes and concentrations. Solubility: H2O.
n
Storage
n
Store at -20°C, protected from light. Stated shelf life 3 years from date of manufacture. Always confirm against the Certificate of Analysis supplied with your batch. Reported half-life in the research literature: ~26 minutes.
n
Research use only — not for human or veterinary use, food, cosmetic or therapeutic application. ADIPHEX supplies this item as a laboratory reference material; no dosing or administration guidance is provided.
n
Frequently asked questions
n
What is Tesamorelin 2mg?
n
GHRH(1-44) analogue with N-terminal fatty acid · 44-residue peptide. GHRH analog; studied in visceral-fat, GH/IGF-1 research. ADIPHEX supplies it as a research reference material only.
n
What is the CAS number for Tesamorelin 2mg?
n
218949-48-5. Molecular formula C221H366N72O67S. Molecular weight 5135.78 g/mol.
n
How should Tesamorelin 2mg be stored?
n
At -20°C, protected from light, with a stated shelf life of 3 years. The batch Certificate of Analysis is the controlling document.
n
Certificate of Analysis
Reconstitution
For peptides supplied as lyophilised powder, reconstitute in bacteriostatic water or sterile saline at the concentration appropriate to your protocol. Allow the vial to come to room temperature before opening, add solvent slowly down the inside wall (do not directly onto the powder), and gently invert until clear. Do not vortex.
Reconstituted solutions are typically stable at 2–8°C for the durations published in the corresponding peer-reviewed reference. For long-term storage, aliquot and freeze at −20°C; avoid repeated freeze–thaw cycles.
Research literature
Selected peer-reviewed publications from PubMed referencing this compound. Provided for research orientation — not an endorsement of any clinical application. Each citation links to the canonical PubMed record.
-
Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors.
Russo SC et al. · AIDS (London, England) · 2024
PubMed PMID 38905488 -
Tesamorelin.
Grunfeld C et al. · Nature reviews. Drug discovery · 2011
PubMed PMID 21283099
You may also need
